# A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

> **NCT05387980** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 1128 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** CIBINQO

## Key facts

- **NCT ID:** NCT05387980
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-19
- **Primary completion:** 2028-11-01
- **Final completion:** 2028-11-01
- **Target enrollment:** 1128 (ACTUAL)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05387980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05387980, "A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05387980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*